Maxillary Sinusitis
14
2
2
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
7.1%
1 terminated out of 14 trials
87.5%
+1.0% vs benchmark
43%
6 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (14)
Single-step Functional Sinus Endoscopy and Transoral Surgery
Endoscopic Sinus Surgery in Recurrent Acute Rhinosinusitis
Balloon Sinuplasty Efficiency in Maxillary Rhinosinusitis.
Assessment of Relationship Between Maxillary Sinus Floor and Maxillary Posterior Teeth Root Tips Position
Microarray Analysis of Sinus Samples From Patients With and Without Chronic Rhinosinusitis
Endosseous Oroantral Port for Minimal Intervention in Treating Chronic Sinusitis
Study Designed to Clinically Evaluate Sinus Wash Device Prototypes
Trial to Evaluate Time to Symptom Relief and Elimination of Infecting Bacteria in Treating Sinusitis With Avelox
Non-Interventional Open Label Prospective Comparative Observational Study Of Evaluation Of Compliance In The Empiric Treatment With Azithromycin SR Versus Amoxiclav 1000 Mg In Adult Patients With Of Acute Bacterial Maxillary Sinusitis
AMS VS MOXI Ketek vs Avelox in AMS
A Study of the Safety and Effectiveness of Levofloxacin Compared With Amoxicillin/Clavulanate Potassium in the Treatment of Adults With Rapid Onset of Severe Inflammation/Infection of the Sinuses
A Study Evaluating the Safety and Efficacy of Treating Sinus Infection With Levofloxacin 750 mg for 5 Days.
A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Sinus Infections in Adults
Study to Measure the Impact of Antibiotics on Bacterial Flora in Adults With Acute Sinusitis